Search This Blog

Sunday, October 11, 2015

Lilly Acquires Phase III Intranasal Glucagon from Locemia Solutions (NYSE:LLY)

Intranasal Glucagon Could be the First Needle-Free Rescue Treatment for Severe Hypoglycemia



Lilly Acquires Phase III Intranasal Glucagon from Locemia Solutions (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.